The Victoria Mills Dette/Equité
Quel est le Dette/Equité de The Victoria Mills?
Le Dette/Equité de The Victoria Mills Limited est 0.07
Quelle est la définition de Dette/Equité?
Le ratio d'endettement et d'équité est un ratio financier indiquant la proportion relative des capitaux propres et de la dette utilisée pour financer les actifs d'une entreprise.
The debt to equity ratio is generally calculated by dividing debt by equity. The D/E ratio is also known as risk, gearing or leverage. The two components are often taken from the firm's balance sheet or statement of financial position (so-called book value), but the ratio may also be calculated using market values for both, if the company's debt and equity are publicly traded, or using a combination of book value for debt and market value for equity financially. Preferred stock can be considered part of debt or equity. Attributing preferred shares to one or the other is partially a subjective decision but will also take into account the specific features of the preferred shares. When used to calculate a company's financial leverage, the debt usually includes only the long-term debt.
Dette/Equité des entreprises dans Real Estate secteur sur BSE par rapport à The Victoria Mills
Que fait The Victoria Mills?
The Victoria Mills Limited, together with its subsidiary Victoria Land Private Limited, develops real estate properties in India. It constructs luxury villas in Alibaug. The company was founded in 1913 and is based in Mumbai, India.
Entreprises avec dette/equité similaire à The Victoria Mills
- Propel Funeral Partners a Dette/Equité de 0.07
- St Charles Resources Inc a Dette/Equité de 0.07
- Standard Life UK Smaller Cos. Trust Plc a Dette/Equité de 0.07
- Karuna Therapeutics Inc a Dette/Equité de 0.07
- Black Mountain Ltd a Dette/Equité de 0.07
- eBroker a Dette/Equité de 0.07
- The Victoria Mills a Dette/Equité de 0.07
- Rumble Resources a Dette/Equité de 0.07
- Goldsource Mines a Dette/Equité de 0.07
- Goldsource Mines a Dette/Equité de 0.07
- Neptune Dash Technologies a Dette/Equité de 0.07
- 9 Capital a Dette/Equité de 0.07
- Akers Biosciences Inc a Dette/Equité de 0.07